Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bap AC Study of topical bacteriophage gel for acne vulgaris
jRCTs051230164Active, not recruiting
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Jul 2024
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of bacteriophage gel in acne vulgaris, sponsored by Japan Agency for Medical Research and Development. Primary endpoint: Number of adverse events. Started Jul 2024; status: active, not recruiting.
02
Drugs
bacteriophage gel
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on jRCTs051230164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051230164.